Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study to settle: laser or PRP for acne scars?

NCT ID NCT07189923

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will compare two common treatments for acne scars: ablative fractional CO2 laser and platelet-rich plasma (PRP) combined with microneedling. 116 adults with moderate to severe atrophic acne scars will receive each treatment on opposite sides of their face. The goal is to see which method improves scars more effectively and safely.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ablative fractional CO2 laser and platelet-rich plasma (PRP) with microneedling
What this could lead to
If this works, it could show which treatment is better for reducing acne scars, helping doctors choose the most effective option.
What could go wrong
This is a small, early-stage study that hasn't started yet. Results may not apply to everyone, and both treatments have risks like redness, swelling, or scarring.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 116 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2025

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (age \>18 years) * Both male and female sex * Patients with grade 2 to grade 4 acne scars, classified on the basis of Goodman's Qualitative classification. * Patient with equal Goodman's Qualitative scores on both halves of the face. * No active acne lesions. * Patients with atrophic scars only. Exclusion Criteria: * Positive history of keloidal tendency. * Positive history of bleeding or platelet disorder. * Positive history of major surgery in past 6 months. * Presence of any acute infection on face like, herpes, folliculitis. * Patients of HIV, HBsAg, or any chronic illness. * Pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ablative fractional co₂ laser therapy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Dhala Medical College

    Dhaka, Bangladesh

More trials for these conditions

Other studies related to the condition(s) this trial covers.